OncoResponse

oncoresponseinc.com

OncoResponse is a biotech company developing antibody-based cancer immunotherapies.

Facts

HQ
Seattle, US
Sectors
Research
Founded
2016
Type
Corporation Seattle business license
Employees
9
Registered name
OncoResponse Inc Seattle business license
Stage
Series D
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about OncoResponse

See all 5

Just–Evotec Biologics opens 130,000 sq ft Redmond J.POD to manufacture COVID‑19 antibody therapeutics for U.S. Defense

Just–Evotec Biologics opened a 130,000 sq ft J.POD drug manufacturing facility in Redmond, Washington that uses continuous, autonomous bioprocessing to design, develop and produce antibody therapeutics more efficiently and at lower cost. The plant will manufacture antibodies for the U.S. Department of Defense to potentially treat COVID-19 and supports both small- and large-scale production for biotech customers globally.

People

  • Clifford Stocks
    Clifford Stocks Founder, Executive Officer, Director, Chief Executive Officer

Online

Questions about OncoResponse

What is OncoResponse?

oncoresponseinc.com

Who are the people behind OncoResponse?

Seattle Flow lists Clifford Stocks (Founder, Executive Officer, Director, Chief Executive Officer) at OncoResponse.

Who invested in OncoResponse, and how much has it raised?

Members of Seattle Flow see OncoResponse's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is OncoResponse based?

OncoResponse is headquartered in Seattle, US.

When was OncoResponse founded?

OncoResponse was founded in 2016.

How many people work at OncoResponse?

OncoResponse has 9 employees.